Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 101 to 150 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
101\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"INOSITOL POLYPHOSPHATE-4-PHOSPHATASE, TYPE II, 105KD; INOSITOL POLYPHOSPHATE 4-PHOSPHATASE II; 4-PHOSPHATASE II. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.046965\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.125644\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.373794212\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
INPP4B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
102\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SELENIDE,WATER DIKINASE 1 (EC 2.7.9.3) (SELENOPHOSPHATE SYNTHETASE 1) (SELENIUM DONOR PROTEIN 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0620748\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.166067\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.37379371\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SEPHS1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
103\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SELENIDE,WATER DIKINASE 2 (EC 2.7.9.3) (SELENOPHOSPHATE SYNTHETASE 2) (SELENIUM DONOR PROTEIN 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0447647\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.119758\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.373792983\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SEPHS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FLAVOPROTEIN OXIDOREDUCTASE MICAL2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.42874\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.147\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.373792502\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MICAL2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
105\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VAV-2 PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.433722\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.16696\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.371668266\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
VAV2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WISKOTT-ALDRICH SYNDROME PROTEIN INTERACTING PROTEIN (WASP INTERACTING PROTEIN) (PRPL-2 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.23886\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.649898\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.367534598\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
WIPF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
107\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SEQUESTOSOME 1; UBIQUITIN-BINDING PROTEIN P62; PHOSPHOTYROSINE INDEPENDENT LIGAND FOR THE LCK SH2 DOMAIN P62. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0692099\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.188735\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.366704109\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SQSTM1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
108\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"NONSPECIFIC LIPID-TRANSFER PROTEIN, MITOCHONDRIAL PRECURSOR (NSL-TP) (STEROL CARRIER PROTEIN 2) (SCP-2) (STEROL CARRIER PROTEIN X) (SCP-X) (SCPX). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.192957\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.526194\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.366703155\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SCP2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
109\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VINEXIN (SH3-CONTAINING ADAPTOR MOLECULE-1) (SCAM-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.619368\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.70728\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.362780563\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SORBS3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
110\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNA POLYMERASE EPSILON SUBUNIT B (EC 2.7.7.7) (DNA POLYMERASE II SUBUNIT B). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0886771\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.24446\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.362746871\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
POLE2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
111\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEOLYSIN TIA-1 (RNA-BINDING PROTEIN TIA-1) (P40-TIA-1) [CONTAINS: P15-TIA-1]. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.401253\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.10989\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.361525016\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TIA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
112\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0828978\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.229439\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.361306491\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C11orf56\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
113\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY F MEMBER 1 (SWI-SNF COMPLEX PROTEIN P270) (B120). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.182783\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.506093\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.361164845\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARID1A\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
114\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROGRAMMED CELL DEATH PROTEIN 6 (PROBABLE CALCIUM-BINDING PROTEIN ALG- 2). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
PDCD6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
115\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BRG1-BINDING PROTEIN ELD/OSA1; ELD (EYELID)/OSA PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.155731\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.431206\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.36115221\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARID1B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
116\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SORCIN (22 KDA PROTEIN) (CP-22) (V19). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.137538\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.380846\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.361138098\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SRI\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
117\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GRANCALCIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.135756\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.375912\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.361137713\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GCA\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
118\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CALCIUM-DEPENDENT PROTEASE, SMALL SUBUNIT (CALPAIN REGULATORY SUBUNIT) (CALCIUM-ACTIVATED NEUTRAL PROTEINASE) (CANP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.133134\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.368655\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.361134394\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CAPNS1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
119\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEOLYSIN TIAR (TIA-1 RELATED PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.374769\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.03782\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.361111753\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TIAL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
120\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PONSIN; SH3-DOMAIN PROTEIN 5 (PONSIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.795875\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.20689\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.36063193\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SORBS1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
121\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARG/ABL-INTERACTING PROTEIN 2 ISOFORM 2; ARG BINDING PROTEIN 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.864436\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.39909\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.360318287\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SORBS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
122\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SON OF SEVENLESS PROTEIN HOMOLOG 2 (SOS-2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.342509\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.955286\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.358540793\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SOS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
123\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SMALL NUCLEAR RIBONUCLEOPROTEIN SM D1 (SNRNP CORE PROTEIN D1) (SM-D1) (SM-D AUTOANTIGEN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.36177\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.00996\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.358202305\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SNRPD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
124\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SON OF SEVENLESS PROTEIN HOMOLOG 1 (SOS-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.393069\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.09904\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.357647583\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SOS1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
125\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.557991\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.56247\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.357121097\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C9orf41\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
126\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBA/UBX 33.3 KDA PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.375086\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.05643\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.3550505\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
127\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ERO1-LIKE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0588477\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.165745\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.355049624\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
128\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-A10 (HOX-1H) (HOX-1.8) (PL). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.911869\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.59406\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351521939\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HOXA10\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
129\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DELTEX 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.162688\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.462821\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351513868\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DTX2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
130\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-B9 (HOX-2E) (HOX-2.5). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.00641\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.86352\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351459043\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HOXB9\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
131\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-A9 (HOX-1G). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.02451\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.9151\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.35144935\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HOXA9\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
132\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMEOBOX PROTEIN HOX-C9 (HOX-3B). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.0305\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.93235\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351424625\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HOXC9\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
133\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAMMA-AMINOBUTYRIC-ACID RECEPTOR GAMMA-3 SUBUNIT PRECURSOR (GABA(A) RECEPTOR). \vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.290469\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.826637\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.351386401\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
GABRG3\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
134\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; INTERLEUKIN-1 RECEPTOR ASSOCIATED KINASE 4. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
135\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FORKHEAD BOX PROTEIN G1C (FORKHEAD-RELATED PROTEIN FKHL3) (HFK3) (FRAGMENT). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
FOXG1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
136\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSPHATIDYLSERINE RECEPTOR; PHOSPHATIDYLSERINE RECEPTOR BETA. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
JMJD6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
137\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAMMA-AMINOBUTYRIC-ACID RECEPTOR GAMMA-2 SUBUNIT PRECURSOR (GABA(A) RECEPTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.250789\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.713719\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351383388\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GABRG2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
138\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAMMA-AMINOBUTYRIC-ACID RECEPTOR GAMMA-1 SUBUNIT PRECURSOR (GABA(A) RECEPTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.248966\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.708531\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351383355\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GABRG1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
139\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAMMA-AMINOBUTYRIC-ACID RECEPTOR EPSILON SUBUNIT PRECURSOR (GABA(A) RECEPTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.219446\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.624522\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351382337\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GABRE\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
140\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAMMA-AMINOBUTYRIC-ACID RECEPTOR ALPHA-4 SUBUNIT PRECURSOR (GABA(A) RECEPTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.217015\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.617604\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351382115\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GABRA4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
141\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAMMA-AMINOBUTYRIC-ACID RECEPTOR ALPHA-3 SUBUNIT PRECURSOR (GABA(A) RECEPTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.2125\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.604755\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351381965\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GABRA3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
142\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAMMA-AMINOBUTYRIC-ACID RECEPTOR ALPHA-6 SUBUNIT PRECURSOR (GABA(A) RECEPTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.218317\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.62131\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351381758\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GABRA6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
143\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAMMA-AMINOBUTYRIC-ACID RECEPTOR ALPHA-1 SUBUNIT PRECURSOR (GABA(A) RECEPTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.211371\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.601543\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351381364\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GABRA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
144\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAMMA-AMINOBUTYRIC-ACID RECEPTOR ALPHA-2 SUBUNIT PRECURSOR (GABA(A) RECEPTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.211718\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.602532\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351380508\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GABRA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
145\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIMILAR TO EXPRESSED SEQUENCE AA415817. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.306813\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.87318\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351374287\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PDXDC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
146\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NADH-UBIQUINONE OXIDOREDUCTASE B14 SUBUNIT (EC 1.6.5.3) (EC 1.6.99.3) (COMPLEX I-B14) (CI-B14). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0694539\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.197664\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351373543\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NDUFA6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
147\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DELTEX HOMOLOG 1; HDX-1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.177901\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.506388\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351313617\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DTX1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
148\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.474383\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.35049\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351267318\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FKBP15\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
149\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"KH DOMAIN CONTAINING, RNA BINDING, SIGNAL TRANSDUCTION ASSOCIATED 3; SAM68-LIKE PHOSPHOTYROSINE PROTEIN, T-STAR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.230683\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.656717\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351266984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KHDRBS3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
150\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"KH DOMAIN CONTAINING, RNA BINDING, SIGNAL TRANSDUCTION ASSOCIATED 1; GAP-ASSOCIATED TYROSINE PHOSPHOPROTEIN P62 (SAM68). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.176025\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.501115\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.351266675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KHDRBS1\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/